Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
- September 13-15, 2021 (Virtual Conference) - MISSISSAUGA, ON, Sept. 7, 2021 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX:MRV) (OTCQX:MRVFF) d/b/a...
- Blexten Label Expanded to Include Ages as Young as 4 Years Old - - Includes Approval of 2.5mg/mL Oral Solution and 10mg orodispersible (Quick Melt) ...
- Q2 2021 Adjusted Total Revenue - $19.9 million - - Q2 2021 Adjusted EBITDA - $7.4 million - - Blexten Canadian Prescriptions Increased 26%...
- First Asian Partnering Deal for Suvexx - - Up to EUR 1.1 million in upfront and milestone payments - MISSISSAUGA, ON, July 29, 2021 /PRNewswire/ -...
MISSISSAUGA, ON, July 26, 2021 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a...
MISSISSAUGA, ON, July 8, 2021 /PRNewswire/ - Nuvo Pharmaceuticals®Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a...
- Tuesday, June 1st – 3:30 p.m. ET - MISSISSAUGA, ON, May 27, 2021 /PRNewswire/ - Nuvo Pharmaceuticals® Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo...
MISSISSAUGA, ON, May 19, 2021 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a...
MISSISSAUGA, ON, May 17, 2021 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company) a...
- Q1 2021 Adjusted Total Revenue - $14.5 million - - Q1 2021 Adjusted EBITDA - $4.4 million - - Blexten Canadian Prescriptions Increased 22%...
- Tuesday, May 18th – 2:00 p.m. ET - MISSISSAUGA, ON, May 11, 2021 /PRNewswire/ - Nuvo Pharmaceuticals® Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo...
MISSISSAUGA, ON, May 3, 2021 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a...
MISSISSAUGA, ON, April 21, 2021 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare ("Miravo" or "the...
• Bloom Burton & Co. Healthcare Investor Conference - April 21st at 10:00 a.m. EST • • Planet MicroCap Showcase - April 22nd at 10:00 a.m. EST •...
MISSISSAUGA, ON, March 26, 2021 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a ...
- Wednesday, March 24th - 3:30 p.m. EST - MISSISSAUGA, ON, March 11, 2021 /PRNewswire/ - Nuvo Pharmaceuticals® Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a...
MISSISSAUGA, ON, March 8, 2021 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare ("Miravo" or "the Company") ...
- Fiscal Year 2020 Adjusted Total Revenue - $71.0 million - - Fiscal Year 2020 Adjusted EBITDA - $28.4 million - - Blexten Canadian Prescriptions...
- Commercial launch anticipated in Summer 2021 - MISSISSAUGA, ON, March 1, 2021 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF)...
MISSISSAUGA, ON, Feb. 22, 2021 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a...
MISSISSAUGA, ON, Jan. 14, 2021 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a...
MISSISSAUGA, ON, Jan. 13, 2021 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a...
- First European Partnering Deal for Suvexx - - Up to EUR 1.7 million in upfront and milestone payments - MISSISSAUGA, ON, Dec. 21, 2020 /PRNewswire/ ...
- Consolidates to One Single Corporate Brand Identity - MISSISSAUGA, ON, Dec. 18, 2020 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX:NRI)...
- Q3 2020 Adjusted Total Revenue - $16.7 million - - Q3 2020 Adjusted EBITDA - $6.6 million - - Blexten Canadian Prescriptions Increased 30%...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.